As of 2025-07-09, the EV/EBITDA ratio of Vireo Health International Inc (VREO.CN) is 28.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VREO.CN's latest enterprise value is 530.12 mil CAD. VREO.CN's TTM EBITDA according to its financial statements is 18.59 mil CAD. Dividing these 2 quantities gives us the above VREO.CN EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 21.0x | 15.2x |
| Forward P/E multiples | 10.5x - 14.7x | 12.6x |
| Fair Price | 0.26 - 0.59 | 0.47 |
| Upside | -55.2% - 0.2% | -21.0% |
| Date | EV/EBITDA |
| 2025-07-03 | 28.92 |
| 2025-07-02 | 28.92 |
| 2025-06-30 | 27.97 |
| 2025-06-27 | 27.97 |
| 2025-06-26 | 27.01 |
| 2025-06-25 | 26.53 |
| 2025-06-24 | 27.01 |
| 2025-06-23 | 26.05 |
| 2025-06-20 | 27.49 |
| 2025-06-18 | 26.53 |
| 2025-06-17 | 26.05 |
| 2025-06-16 | 27.01 |
| 2025-06-12 | 25.57 |
| 2025-06-11 | 27.01 |
| 2025-06-10 | 24.14 |
| 2025-06-09 | 26.53 |
| 2025-06-06 | 26.53 |
| 2025-06-05 | 25.57 |
| 2025-06-04 | 24.61 |
| 2025-06-03 | 26.05 |
| 2025-06-02 | 25.57 |
| 2025-05-30 | 22.94 |
| 2025-05-29 | 25.09 |
| 2025-05-28 | 25.09 |
| 2025-05-27 | 26.05 |
| 2025-05-23 | 23.66 |
| 2025-05-22 | 23.90 |
| 2025-05-21 | 24.14 |
| 2025-05-20 | 27.49 |
| 2025-05-16 | 23.90 |
| 2025-05-14 | 26.53 |
| 2025-05-13 | 28.44 |
| 2025-05-12 | 26.05 |
| 2025-05-09 | 26.05 |
| 2025-05-08 | 26.05 |
| 2025-05-07 | 25.57 |
| 2025-05-06 | 24.61 |
| 2025-05-05 | 27.01 |
| 2025-05-01 | 30.36 |
| 2025-04-30 | 28.44 |
| 2025-04-29 | 28.92 |
| 2025-04-28 | 26.53 |
| 2025-04-25 | 27.49 |
| 2025-04-24 | 27.97 |
| 2025-04-23 | 24.61 |
| 2025-04-22 | 24.14 |
| 2025-04-21 | 23.66 |
| 2025-04-17 | 25.09 |
| 2025-04-16 | 24.61 |
| 2025-04-15 | 23.66 |